Palo Alto event showcases Harvard tech startup formation

Innovations in gene editing, forming multiple emulsions, stimulating or inhibiting the immune system, and more

‘Unprecedented achievement’ provides sufficient quantities of a fully synthetic halichondrin molecule for clinical trials now underway

Innovations in rehabilitative walking devices, transparent sensors and actuators, conditioning for tissue transplants, microfluidic systems, retrievable information storage using nucleic acids, and more